| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |